1. ER-phagy at a glance
   Paolo Grumati et al, 2018, J Cell Sci CrossRef
2. Hypoxia and Selective Autophagy in Cancer Development and Therapy
   Ioanna Daskalaki et al, 2018, Front. Cell Dev. Biol. CrossRef
3. Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer
   Ferenc Zoltan Takacs et al, 2019, Arch Gynecol Obstet CrossRef
4. Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery
   Fiorenza Fumagalli et al, 2016, Nat Cell Biol CrossRef
5. Let’s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine
   Maximilian Linxweiler et al, 2017, Sig Transduct Target Ther CrossRef
6. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m⁶A-caused stabilization of SEC62.
   Huabo He et al, 2019, Biochem Biophys Res Commun CrossRef
7. Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network
   Lingyu Qi et al, 2019 CrossRef
8. ER-phagy and human diseases
   Christian A. Hübner et al, 2019, Cell Death Differ CrossRef
9. Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling.
   Juan Du et al, 2019, Oncogenesis CrossRef
10. Selective Autophagy of the Protein Homeostasis Machinery: Ribophagy, Proteaphagy and ER-Phagy
    Carsten J. Beese et al, 2020, Front. Cell Dev. Biol. CrossRef
11. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas
    Florian Bochen et al, 2017, Oncotarget CrossRef
12. Expression of 3q oncogene SEC62 in atypical fibroxanthoma‑immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features
    Cornelia M�ller et al, 2018, Oncol Lett CrossRef
13. Ionizing radiation induces epithelial–mesenchymal transition in human bronchial epithelial cells
    Bo Tang et al, 2020 CrossRef
14. Globular adiponectin alleviates chronic intermittent hypoxia-induced H9C2 cardiomyocytes apoptosis via ER-phagy induction
    Qiang Zhang et al, 2020, Cell Cycle CrossRef
15. Negative feedback and modern anti‐cancer strategies targeting the ER stress response
    Yaofu Liu et al, 2020, FEBS Lett CrossRef
16. Autophagy and organelle homeostasis in cancer.
    Dannah R Miller et al, 2021, Dev Cell CrossRef
17. Expression of SEC62 Oncogene in Benign, Malignant and Borderline Melanocytic Tumors—Unmasking the Wolf in Sheep’s Clothing?
    Cornelia S. L. Müller et al, 2021, Cancers CrossRef
18. Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex
    Mark Sicking et al, 2021, Cells CrossRef
19. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma
    Tianzhu Lu et al, 2021, Cancer Med CrossRef
20. SEC62 and SEC63 Expression in Hepatocellular Carcinoma and Tumor-Surrounding Liver Tissue
    Markus Casper et al, 2021, Visc Med CrossRef
21. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
    Qunhao Zheng et al, 2021, BMC Cancer CrossRef
22. Sec62 promotes gastric cancer metastasis through mediating UPR-induced autophagy activation
    Song Su et al, 2022, Cell. Mol. Life Sci. CrossRef
23. Antagonizing Sec62 function in intracellular Ca2+ homeostasis represents a novel therapeutic strategy for head and neck cancer
    Sandrina Körner et al, 2022, Front. Physiol. CrossRef
24. Role of the SEC62 gene in dermato‐oncology – impact on tumor cell biology, prognostication, and personalized therapy management
    Maximilian Linxweiler et al, 2022, J Deutsche Derma Gesell CrossRef
25. Rolle des SEC62 ‐Gens in der Dermatoonkologie – Relevanz für die Tumorzellbiologie, Prognoseeinschätzung und personalisierte Therapieplanung
    Maximilian Linxweiler et al, 2022, J Deutsche Derma Gesell CrossRef
26. The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors
    Julia S. M. Zimmermann et al, 2022, Front. Physiol. CrossRef
27. null
    Armin Melnyk et al, 2023 CrossRef
28. Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia
    Julia C. Radosa et al, 2023, Front. Physiol. CrossRef
29. The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer
    Julia C. Radosa et al, 2023, IJMS CrossRef
30. Dual Sec62/Ki67 immunocytochemistry of liquid‐based cytological preparations represents a highly valid biomarker for non‐invasive detection of head and neck squamous cell carcinomas
    Jan Philipp Kühn et al, 2024, Cytopathology CrossRef
31. Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation
    Maximilian Linxweiler et al, 2023, Cancers CrossRef
32. Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
    Toyaja Jadhav et al, 2024 CrossRef